Similar articles

• Trial of amifostine in autologous stem cell transplant.

  Sastry P, Bhagwat R, Biswas G, Khadwal A, Narayanan P, Bakshi A, Parikh P. Sastry P, et al. Bone Marrow Transplant. 2006 Jan;37(1):117-8. doi: 10.1038/sj.bmt.1705204. Bone Marrow Transplant. 2006. PMID: 16273114 Clinical Trial. No abstract available.
• Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.

  Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM. Costa LJ, et al. Br J Haematol. 2008 Oct;143(2):268-73. doi: 10.1111/j.1365-2141.2008.07342.x. Epub 2008 Aug 10. Br J Haematol. 2008. PMID: 18699848
• High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.

  Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E. Wang EH, et al. Bone Marrow Transplant. 2004 Oct;34(7):581-7. doi: 10.1038/sj.bmt.1704637. Bone Marrow Transplant. 2004. PMID: 15273714
• Capnocytophaga gingivalis bacteremia detected only on quantitative blood cultures in a child with leukemia.

  Mantadakis E, Danilatou V, Christidou A, Stiakaki E, Kalmanti M. Mantadakis E, et al. Pediatr Infect Dis J. 2003 Feb;22(2):202-4. Pediatr Infect Dis J. 2003. PMID: 12613461 Review.
• Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.

  Kashyap A, Snowden J. Kashyap A, et al. J Rheumatol Suppl. 2001 Oct;64:39-41. J Rheumatol Suppl. 2001. PMID: 11642503 Review.